In breast and thyroid cancer, overexpressed miR-222-3p induces proliferation, migration, and invasion, while in castration-resistant prostate cancer, exosomal miR-222-3p upregulates such malignant behaviors by activating mTOR signaling [23,24,25]. Here, MTOR is linked to prostate carcinoma.